Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kelly

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
Urology Case Reports|October 8, 2016
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case ReportHyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate CancerSusan Halabi, William Kevin Kelly, Hua Ma, et al.
JAMA Oncology|February 17, 2017
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical TrialsEthan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Cell|August 14, 2018
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear ImportVeronica Rodriguez-Bravo, Raffaella Pippa, Won-Min Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2016
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyDaniel L Hertz, Kouros Owzar, Sherrie Lessans, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USARebecca Earnest, Rockib Uddin, Nicholas Matluk, et al.
Medrxiv : the Preprint Server for Health Sciences|July 7, 2021
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineagesMary E Petrone, Jessica E Rothman, Mallery I Breban, et al.
Communications Biology|May 11, 2022
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and IotaMary E Petrone, Jessica E Rothman, Mallery I Breban, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Urology Case Reports|October 8, 2016
Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case ReportHyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2016
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate CancerSusan Halabi, William Kevin Kelly, Hua Ma, et al.
JAMA Oncology|February 17, 2017
Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical TrialsEthan Basch, Amylou C Dueck, Lauren J Rogak, et al.
Cell|August 14, 2018
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear ImportVeronica Rodriguez-Bravo, Raffaella Pippa, Won-Min Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2016
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyDaniel L Hertz, Kouros Owzar, Sherrie Lessans, et al.
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
Medrxiv : the Preprint Server for Health Sciences|October 13, 2021
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USARebecca Earnest, Rockib Uddin, Nicholas Matluk, et al.
Medrxiv : the Preprint Server for Health Sciences|July 7, 2021
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineagesMary E Petrone, Jessica E Rothman, Mallery I Breban, et al.
Communications Biology|May 11, 2022
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and IotaMary E Petrone, Jessica E Rothman, Mallery I Breban, et al.
Pageof 26